Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of a Single-Dose of NN2211, a Long-Acting Glucagon-Like Peptide 1 Derivative, in Healthy Male Subjects

Abstract

This study provides evidence that NN2211 has a pharmacokinetic profile consistent with once-daily dosing in humans.